Identifying hepatocellular carcinoma patients with survival benefits from surgery combined with chemotherapy: based on machine learning model

BACKGROUND: Hepatocellular carcinoma (HCC) is still fatal even after surgical resection. The purpose of this study was to analyze the prognostic factors of 5-year survival rate and to establish a model to identify HCC patients with gain of surgery combined with chemotherapy. METHODS: All patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jie, Gong, Ni, Li, Dan, Deng, Youyuan, Chen, Jiawei, Luo, Dingan, Zhou, Wei, Xu, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714169/
https://www.ncbi.nlm.nih.gov/pubmed/36451200
http://dx.doi.org/10.1186/s12957-022-02837-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714169/
https://www.ncbi.nlm.nih.gov/pubmed/36451200
http://dx.doi.org/10.1186/s12957-022-02837-2

Ejemplares similares